Shari Bernice Duwenhoegger, is a
Licensed Practical Nurse based in Maple Grove, Minnesota. Shari Bernice Duwenhoegger is licensed to practice in Minnesota (license number L59057-8) and her current practice location is
9037 Garland Ln N, Maple Grove, Minnesota. She can be reached at her office (for appointments etc.) via phone at
(612) 481-5629.
NPI number for Shari Bernice Duwenhoegger is 1780143453 and her current mailing address is 9037 Garland Ln N, Maple Grove, Minnesota. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1780143453.
Provider's Profile
Full Name | Shari Bernice Duwenhoegger |
---|
Gender | Female |
---|
Speciality | Licensed Practical Nurse |
---|
Location | 9037 Garland Ln N, Maple Grove, Minnesota |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1780143453
- Provider Enumeration Date: 03/13/2019
- Last Update Date: 03/13/2019
Medical Identifiers
Medical identifiers for Shari Bernice Duwenhoegger such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1780143453 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
164W00000X | Licensed Practical Nurse | L59057-8 (Minnesota) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shari Bernice Duwenhoegger is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Shari Bernice Duwenhoegger, 9037 Garland Ln N, Maple Grove, MN 55311-1285 Ph: (612) 481-5629 | Shari Bernice Duwenhoegger, 9037 Garland Ln N, Maple Grove, MN 55311-1285 Ph: (612) 481-5629 |
Reviews and Comments